https://ansm.sante.fr/informations-de-securite/clariscan-0-5-mmol-ml-solution-injectable-en-seringue-pre-remplie-15-et-20-ml-precaution-pour-limiter-le-risque-de-mouvement-du-piston-lors-de-linjection 2023 false false false France French guidelines for drug use pharmacovigilance note injections, intravenous contrast media gadoterate meglumine Syringe issue